Inconsistency between serum IgG κ and glomerular IgA λ chain types in proliferative glomerulonephritis with monoclonal deposits successfully treated with daratumumab-based therapy
This rare case of PGNMID showed a discrepancy between serum IgG κ and glomerular IgA λ chain. Treatment with daratumumab, bortezomib, and dexamethasone significantly reduced serum FLC levels and stabilized the blood creatinine level. Daratumumab is a promising drug for the treatment of PGNMID.
Authors
- DUQUN CHEN
- Liping Guo
- Zhezhe Niu
- Yaling Bai
- Rongfang Zhu
- Yi-Xiang Wang (ORCID: https://orcid.org/0000-0002-4021-4228)
- Meijuan Cheng
- Guolei Zhang
- Zhen Cheng
- Huihui Chen
- Jingjing Jin
- Jinsheng Xu
Institutions
- Hebei Medical University (CN)
- Third Hospital of Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Medicine
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1097/md.0000000000044607
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00